MedTrace Logo

Surgical Correction of Moderate Ischemic Mitral Regurgitation

NCT00394797 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2011-06-01

No results posted yet for this study

Summary

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Conditions

  • Moderate Ischemic Mitral Regurgitation

Interventions

PROCEDURE

mitral valve annuloplasty

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Shuli Silberman, MD · Shaare Zedek Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394797 on ClinicalTrials.gov